Last reviewed · How we verify
NCT06294743
Posterior Tibia Nerve Neuroprolotherapy for Dysmenorrhea
EARLY_PHASE1 trial testing Posterior tibial nerve neuroprolotherapy in Dysmenorrhea in 60 participants. Status unknown.
31 December 2025
Quick facts
| Lead sponsor | Taichung Armed Forces General Hospital |
|---|---|
| Phase | EARLY_PHASE1 |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 60 |
| Start date | 23 November 2023 |
| Primary completion | 31 December 2025 |
| Estimated completion | 31 December 2025 |
| Sites | 1 location across Taiwan |
Drugs / interventions tested
- Posterior tibial nerve neuroprolotherapy
- Acetaminophen 500Mg Tab — full drug profile →
Conditions studied
- Dysmenorrhea — all drugs for Dysmenorrhea →
- Prolotherapy — all drugs for Prolotherapy →
Sponsor
Taichung Armed Forces General Hospital
Who can join
Adults 18 to 50, female only, with Dysmenorrhea or Prolotherapy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this crossover study is to assessed the treatment efficacy of posterior tibia nerve neuroprolotherapy on dysmenorrhea. The primary outcome is the improvement of Visual Analogue Scale. The main question it aims to answer is: •Could the posterior tibial nerve neuroprolotherapy alleviate the pain of dysmenorrhea. Participants will be randomly allocated into two groups, Group-1 will receive neuroprolotherapy in the first 2 menstrual cycles followed by oral acetaminophen(500mg) for the subsequent 2 menstrual cycles. Group02 will received oral acetaminophen(500mg) in initial 2 menstrual cycles, followed by receiving neuroprolotherapy for the subsequent 2 menstrual cycles.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06294743
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Dysmenorrhea
Currently open trials in the same condition.
- NCT07209566 — A Research Study Exploring How Musculoskeletal Function and the Autonomic Nervous System Relate to Visceral Pain in Wome · NA · recruiting
- NCT07248540 — IV Magnesium in the Treatment of Acute Dysmenorrhea · NA · recruiting
- NCT07036913 — Effectiveness of ST With TENS and Stretching Exercises on Menstrual Pain and QOL With Dysmenorrhea. RCT · NA · active not recruiting
- NCT07081789 — Music and Puzzle Use in Dysmenorrhea Relief · NA · active not recruiting
- NCT06741059 — Effect of TENS on Pain and Symptoms in Primary Dysmenorrhea · NA · recruiting
Other Taichung Armed Forces General Hospital trials
Trials by the same sponsor.
- NCT06262542 — Efficacy and Safety of Chinese Herb Medicine-Moxibustion Therapy on Chemotherapy-Induced Leukopenia · NA · recruiting
- NCT06020963 — Can Acupoint Low Intensity Shockwave Therapy Improve Bladder Voiding Efficiency · NA · unknown
- NCT05485142 — The Treatment Efficacy of Prolotherapy in Bladder Voiding Dysfunction · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06294743 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Taichung Armed Forces General Hospital
- Last refreshed: 6 March 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06294743.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing